SlideShare a Scribd company logo
1 of 11
TIVA Pharmaceutical Industries Ltd. VikramGole MBA (Pharma Management), 2010-12 Batch MGM University Of Health Sciences, MGM School of Biomedical Sciences, Navi Mumbai
TEVA PHARMACEUTICAL INDST. LTD. TEVA is a global pharmaceutical company Specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as API TEVA is among the top 15 pharmacompanies  Among the largest generic pharmaceuticalcompanies in the world. Chairmen,MD & CEO is Mr.EliHurvitz. http://www.tevapharm.com/
TEVA PHARMACEUTICAL INDST. LTD. Headquartered inJerusalem, Israel. Tevais the world's largest generic drug maker A global product portfolio of more than 1,450 molecules  Direct presence in about 60 countries.  Teva'sbranded businesses focus on neurological, respiratory and women's health therapeutic areas  Teva'sleading innovative product is Copaxone® Copaxone® number one prescribed treatment for relapsing-remitting multiple sclerosis.  Teva employs approximately 40,000 people around the world Reached $16.1 billion in net sales in 2010. http://www.tevapharm.com/financial/acquisitions.asp
MISSION To play a leading role in the transformation of the healthcare system through its presence in the development, manufacture, and marketing of generic pharmaceuticals. http://www.tevausa.com/defoult.aspx?pageid=31
History And Development 1901 :Founded in Jerusalem, Israel as small wholesale drug business. Importing and distributing Drugs by loading on back of camels and donkeys. 1930:- started small scale manufacturing plant which faced lots of difficulties in mfg. 1940-50:- 2nd world war makes country dependent on small scale producer( import difficulties) http://www.tevausa.com/history/
Cont… 1948:-results in Rapid growth in Local market and started Export of drugs. 1951:-raised capital from public market and became first industrial Co. in capital market 1964:-Teva , Assia and Zori merged by forming TevapharmaInds. Ltd, Israel's largest health care company. Decades of Beginning of export and and new markets for Teva.  http://www.tevausa.com/..../history/
Cont… 1980:- Aquire second largest Israeli drug manufacture Ikapharm which enables Teva in separate penicillin production. 1982:- Ikapharm plant got USFDA approval and Teva got entry in US market. 1984:- Teva acquire Miganda Ltd, disposable medical device company. 1986:-Acquire Lemmon (small manufacturer) give entry in  American Market. http://www.tevausa.com/..../history/
Cont… 1988:- Teva bought Abic, second largest Israeli pharma Co. and became Israel’s largest and most successful Co. 1990s:- Teva  continue to expand and became major player in Global Generic market by M&A. This decade saw fruit of incentives in 10yrs R&D by launch of Copaxone® (Multiple Sclerosis) 2000:- Teva’sAcquisition of Novopharm, makes Teva as largest generic pharma co. in  North America. http://www.tevausa.com/..../history/
Cont… 2004:- Sicor became fully owned subsidory of Teva. ( Brings Two premier generic pharma company together.) 2006:- Acquisition of IVAX Corp. brings strong presence in Latin America, Central & eastern Europe, North America & Europe. Got Diversify into all Areas of therapeutics and Veterinary Generics. http://www.tevausa.com/..../history/
Cont… 2010 :-Reached $16.1 billion in net sales. May 2011:- Teva Acquire 57% of shares in Taiyo Pharmaceutical Industry Co. Ltd.( 3rd Largest generic player in Japan) for $460 million in cash.  Teva employs approximately 40,000 people around the world. http://www.tevausa.com/..../history/
Thank You…..

More Related Content

Viewers also liked

Reg Export Strategy for CARIFORUM Creative Industries - Music VCA Report
Reg Export Strategy for CARIFORUM Creative Industries - Music VCA ReportReg Export Strategy for CARIFORUM Creative Industries - Music VCA Report
Reg Export Strategy for CARIFORUM Creative Industries - Music VCA Report
Katrine Smith
 
Biotechnology 1
Biotechnology 1Biotechnology 1
Biotechnology 1
sokraturk
 
LGM Pharma - Specialty API Portfolio
LGM Pharma - Specialty API PortfolioLGM Pharma - Specialty API Portfolio
LGM Pharma - Specialty API Portfolio
LGM Pharma
 
Project, Program & Portfolio Management
Project, Program & Portfolio ManagementProject, Program & Portfolio Management
Project, Program & Portfolio Management
Anand Subramaniam
 

Viewers also liked (16)

Cluster Workshop - Belgrade June 22, 2010
Cluster Workshop - Belgrade June 22, 2010Cluster Workshop - Belgrade June 22, 2010
Cluster Workshop - Belgrade June 22, 2010
 
Reg Export Strategy for CARIFORUM Creative Industries - Music VCA Report
Reg Export Strategy for CARIFORUM Creative Industries - Music VCA ReportReg Export Strategy for CARIFORUM Creative Industries - Music VCA Report
Reg Export Strategy for CARIFORUM Creative Industries - Music VCA Report
 
Global Pharma report 2014
Global Pharma report 2014Global Pharma report 2014
Global Pharma report 2014
 
Biotechnology 1
Biotechnology 1Biotechnology 1
Biotechnology 1
 
Pfizer project management
Pfizer project managementPfizer project management
Pfizer project management
 
Pharma Product Portfolio 2011 210211
Pharma Product Portfolio 2011 210211Pharma Product Portfolio 2011 210211
Pharma Product Portfolio 2011 210211
 
Project lifecycle management @ Pharma Project Management Conference - 2014, M...
Project lifecycle management @ Pharma Project Management Conference - 2014, M...Project lifecycle management @ Pharma Project Management Conference - 2014, M...
Project lifecycle management @ Pharma Project Management Conference - 2014, M...
 
Reference standards in Pharmaceutical Industries
Reference standards in Pharmaceutical IndustriesReference standards in Pharmaceutical Industries
Reference standards in Pharmaceutical Industries
 
LGM Pharma - Specialty API Portfolio
LGM Pharma - Specialty API PortfolioLGM Pharma - Specialty API Portfolio
LGM Pharma - Specialty API Portfolio
 
Introduction to project, program & portfolio management
Introduction to project, program & portfolio managementIntroduction to project, program & portfolio management
Introduction to project, program & portfolio management
 
P3M - Project, Program, Portfolio Management Framework
P3M - Project, Program, Portfolio Management FrameworkP3M - Project, Program, Portfolio Management Framework
P3M - Project, Program, Portfolio Management Framework
 
European Union
European UnionEuropean Union
European Union
 
Creative industries: EU Policy: McGill Globalization Forum
Creative industries: EU Policy: McGill Globalization ForumCreative industries: EU Policy: McGill Globalization Forum
Creative industries: EU Policy: McGill Globalization Forum
 
Project, Program & Portfolio Management
Project, Program & Portfolio ManagementProject, Program & Portfolio Management
Project, Program & Portfolio Management
 
Guide to Project Portfolio Management
Guide to Project Portfolio ManagementGuide to Project Portfolio Management
Guide to Project Portfolio Management
 
Enhancing Pharma Compliance – Why Digitize the Compliance Process?
Enhancing Pharma Compliance – Why Digitize the Compliance Process?Enhancing Pharma Compliance – Why Digitize the Compliance Process?
Enhancing Pharma Compliance – Why Digitize the Compliance Process?
 

Recently uploaded

Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 

Recently uploaded (20)

Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 

Tiva pharmaceutical industries ltd

  • 1. TIVA Pharmaceutical Industries Ltd. VikramGole MBA (Pharma Management), 2010-12 Batch MGM University Of Health Sciences, MGM School of Biomedical Sciences, Navi Mumbai
  • 2. TEVA PHARMACEUTICAL INDST. LTD. TEVA is a global pharmaceutical company Specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as API TEVA is among the top 15 pharmacompanies Among the largest generic pharmaceuticalcompanies in the world. Chairmen,MD & CEO is Mr.EliHurvitz. http://www.tevapharm.com/
  • 3. TEVA PHARMACEUTICAL INDST. LTD. Headquartered inJerusalem, Israel. Tevais the world's largest generic drug maker A global product portfolio of more than 1,450 molecules Direct presence in about 60 countries. Teva'sbranded businesses focus on neurological, respiratory and women's health therapeutic areas Teva'sleading innovative product is Copaxone® Copaxone® number one prescribed treatment for relapsing-remitting multiple sclerosis. Teva employs approximately 40,000 people around the world Reached $16.1 billion in net sales in 2010. http://www.tevapharm.com/financial/acquisitions.asp
  • 4. MISSION To play a leading role in the transformation of the healthcare system through its presence in the development, manufacture, and marketing of generic pharmaceuticals. http://www.tevausa.com/defoult.aspx?pageid=31
  • 5. History And Development 1901 :Founded in Jerusalem, Israel as small wholesale drug business. Importing and distributing Drugs by loading on back of camels and donkeys. 1930:- started small scale manufacturing plant which faced lots of difficulties in mfg. 1940-50:- 2nd world war makes country dependent on small scale producer( import difficulties) http://www.tevausa.com/history/
  • 6. Cont… 1948:-results in Rapid growth in Local market and started Export of drugs. 1951:-raised capital from public market and became first industrial Co. in capital market 1964:-Teva , Assia and Zori merged by forming TevapharmaInds. Ltd, Israel's largest health care company. Decades of Beginning of export and and new markets for Teva. http://www.tevausa.com/..../history/
  • 7. Cont… 1980:- Aquire second largest Israeli drug manufacture Ikapharm which enables Teva in separate penicillin production. 1982:- Ikapharm plant got USFDA approval and Teva got entry in US market. 1984:- Teva acquire Miganda Ltd, disposable medical device company. 1986:-Acquire Lemmon (small manufacturer) give entry in American Market. http://www.tevausa.com/..../history/
  • 8. Cont… 1988:- Teva bought Abic, second largest Israeli pharma Co. and became Israel’s largest and most successful Co. 1990s:- Teva continue to expand and became major player in Global Generic market by M&A. This decade saw fruit of incentives in 10yrs R&D by launch of Copaxone® (Multiple Sclerosis) 2000:- Teva’sAcquisition of Novopharm, makes Teva as largest generic pharma co. in North America. http://www.tevausa.com/..../history/
  • 9. Cont… 2004:- Sicor became fully owned subsidory of Teva. ( Brings Two premier generic pharma company together.) 2006:- Acquisition of IVAX Corp. brings strong presence in Latin America, Central & eastern Europe, North America & Europe. Got Diversify into all Areas of therapeutics and Veterinary Generics. http://www.tevausa.com/..../history/
  • 10. Cont… 2010 :-Reached $16.1 billion in net sales. May 2011:- Teva Acquire 57% of shares in Taiyo Pharmaceutical Industry Co. Ltd.( 3rd Largest generic player in Japan) for $460 million in cash. Teva employs approximately 40,000 people around the world. http://www.tevausa.com/..../history/